-afil
A PDE5 inhibitor: relaxes smooth muscle in blood vessels; used for erectile dysfunction and pulmonary hypertension.
- Drugs ending in -afil: 6
- Approved somewhere: 4
- With a US drug page: 4
- Stem
- -afil
- Class
- PDE5 blockers that widen blood vessels, like sildenafil
- Most common targets
- PDE5A (6)
Approved and clinical-stage drugs in ChEMBL whose names ending in -afil, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Avanafil | Approved | PDE5A | Phosphodiesterase 5A inhibitor |
| Sildenafil | Approved | PDE5A | Phosphodiesterase 5A inhibitor |
| Tadalafil | Approved | PDE5A | Phosphodiesterase 5A inhibitor |
| Vardenafil | Approved | PDE5A | Phosphodiesterase 5A inhibitor |
| Udenafil | Phase 3 | PDE5A | Phosphodiesterase 5A inhibitor |
| Gisadenafil | Phase 2 | PDE5A | Phosphodiesterase 5A inhibitor |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO